To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

A British-made prostate cancer test could avoid the need for biopsies in four out of five cases, according to a study. The EpiSwitch PSE next generation blood test uses advances in technology to ...

A prostate cancer biomarker test that utilizes 17 genetic markers has demonstrated a high degree of accuracy in screening for serious cancer. The test also significantly reduced unnecessary biopsies ...

Please provide your email address to receive an email when new articles are posted on . A urine-based test helped reduce unnecessary biopsies among men with prostate cancer. The test appeared to be ...

Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate cancer will be detected too late. A simple urine test may be able to ...

Please provide your email address to receive an email when new articles are posted on . Stockholm3 blood test could have reduced unnecessary biopsies by almost half compared with PSA screening alone.

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...